Who is the CEO of MBX? | Glauxie AI

Q: Who is the CEO of MBX?

MBX Biosciences, Inc. Common Stock (MBX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Peter Kent Hawryluk. MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its... Employees: 120,000.

Q: What does MBX company do?

Learn what MBX does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling MBX?

Track recent insider buys and sells for MBX with transaction details, amounts, and trends.

Q: What sector is MBX in?

Find MBX sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of MBX?

🦉

MBX Biosciences, Inc. Common Stock (MBX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOPeter Kent Hawryluk

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2...

Key Executives

Name	Title
Andreas Moraitis	Senior Vice President of Clinical Development
Chatan Charan	Senior Vice President of Pharmaceutical Development & Chemistry, Manufacturing and Controls
John W. Smither	Interim Chief Financial Officer
Karen Basbaum	Chief Business Officer
Mark Hope	Senior Vice President of Regulatory & Quality
Michael A. Dorato DABT	Sr. Vice President of Discovery & Non-Clinical Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

MBX Profile Financials

What does MBX company do? Are insiders buying or selling MBX? What sector is MBX in?